Literature DB >> 8514891

Analysis of T helper and antigen-presenting cell functions in cord blood and peripheral blood leukocytes from healthy children of different ages.

M Clerici1, L DePalma, E Roilides, R Baker, G M Shearer.   

Abstract

The development of antigen-specific functional T lymphocyte immunity in infants and children is an area of immunology that needs elucidation. Leukocytes from cord blood (CBL) and from PBL of children of different ages who were in the hospital for minor surgical procedures were compared with PBL from healthy adults for their ability to generate T helper cell (Th) responses assessed by in vitro proliferation and IL-2 production after stimulation with: influenza A virus (FLU); tetanus toxoid (TET); adult allogeneic PBL that were either undepleted (ALLO) or depleted of adherent antigen presenting cells (ALLONW); and PHA. CBL generated Th responses to ALLONW, ALLO, and PHA, but not to FLU or TET. PBL from infants between 6 and 13 mo of age responded to ALLO and PHA; none responded to FLU or ALLONW, and two of four responded weakly to TET. PBL from children between 13 and 26 mo of age responded to all stimuli except FLU, to which only one child responded marginally. PBL from children older than 36 mo responded to all stimuli at levels comparable to those of PBL from adults. The use of undepleted and adherent cell-depleted CBL and PBL from children of different ages as allogeneic stimulators of responses generated by PBL from adults indicated that the antigen presenting function of CBL and PBL from children 13 mo or older are sufficiently developed to present alloantigen, whereas PBL from children younger than 13 mo are not. Therefore, our results indicate that age-dependent differences exist in both T helper and antigen-presenting functions of CBL and PBL from children of different ages. Surprisingly, CBL appear to be more efficient in antigen-presenting function than PBL from children younger than 13 mo. These findings are important for establishing developmental parameters of T helper cell immunity relevant for pediatric infection and transplantation in infants and children.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8514891      PMCID: PMC443351          DOI: 10.1172/JCI116526

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  18 in total

Review 1.  Human immunodeficiency virus infection in children.

Authors:  J Falloon; J Eddy; L Wiener; P A Pizzo
Journal:  J Pediatr       Date:  1989-01       Impact factor: 4.406

Review 2.  Acquisition of immunologic self-tolerance.

Authors:  R H Schwartz
Journal:  Cell       Date:  1989-06-30       Impact factor: 41.582

3.  Detection of three distinct patterns of T helper cell dysfunction in asymptomatic, human immunodeficiency virus-seropositive patients. Independence of CD4+ cell numbers and clinical staging.

Authors:  M Clerici; N I Stocks; R A Zajac; R N Boswell; D R Lucey; C S Via; G M Shearer
Journal:  J Clin Invest       Date:  1989-12       Impact factor: 14.808

4.  Ontogeny of expression of UCHL1 antigen on TcR-1+ (CD4/8) and TcR delta+ T cells.

Authors:  A R Hayward; J Lee; P C Beverley
Journal:  Eur J Immunol       Date:  1989-04       Impact factor: 5.532

5.  Decreased production of interferon-gamma by human neonatal cells. Intrinsic and regulatory deficiencies.

Authors:  C B Wilson; J Westall; L Johnston; D B Lewis; S K Dower; A R Alpert
Journal:  J Clin Invest       Date:  1986-03       Impact factor: 14.808

6.  Deficiency of immune interferon production by leukocytes of normal newborns.

Authors:  Y J Bryson; H S Winter; S E Gard; T J Fischer; E R Stiehm
Journal:  Cell Immunol       Date:  1980-09-15       Impact factor: 4.868

7.  Human immunodeficiency virus infection in the US Air Force: seroconversions, clinical staging, and assessment of a T helper cell functional assay to predict change in CD4+ T cell counts.

Authors:  D R Lucey; G P Melcher; C W Hendrix; R A Zajac; D W Goetz; C A Butzin; M Clerici; R D Warner; S Abbadessa; K Hall
Journal:  J Infect Dis       Date:  1991-10       Impact factor: 5.226

8.  Defective IFN-gamma production in the human neonate. I. Dysregulation rather than intrinsic abnormality.

Authors:  N Wakasugi; J L Virelizier
Journal:  J Immunol       Date:  1985-01       Impact factor: 5.422

9.  Human memory T lymphocytes express increased levels of three cell adhesion molecules (LFA-3, CD2, and LFA-1) and three other molecules (UCHL1, CDw29, and Pgp-1) and have enhanced IFN-gamma production.

Authors:  M E Sanders; M W Makgoba; S O Sharrow; D Stephany; T A Springer; H A Young; S Shaw
Journal:  J Immunol       Date:  1988-03-01       Impact factor: 5.422

10.  Cord blood macrophages present bacterial antigen (Escherichia coli) to paternal T cells.

Authors:  G J Zlabinger; J W Mannhalter; M M Eibl
Journal:  Clin Immunol Immunopathol       Date:  1983-09
View more
  27 in total

Review 1.  Immune mechanisms of childhood asthma.

Authors:  C E Donovan; P W Finn
Journal:  Thorax       Date:  1999-10       Impact factor: 9.139

2.  Long-term pertussis-specific immunity after primary vaccination with a combined diphtheria, tetanus, tricomponent acellular pertussis, and hepatitis B vaccine in comparison with that after natural infection.

Authors:  S Esposito; T Agliardi; A Giammanco; G Faldella; A Cascio; S Bosis; O Friscia; M Clerici; N Principi
Journal:  Infect Immun       Date:  2001-07       Impact factor: 3.441

Review 3.  Defective antigen-presenting cell function in human neonates.

Authors:  Paula A Velilla; Maria T Rugeles; Claire A Chougnet
Journal:  Clin Immunol       Date:  2006-09-28       Impact factor: 3.969

4.  A Novel R848-Conjugated Inactivated Influenza Virus Vaccine Is Efficacious and Safe in a Neonate Nonhuman Primate Model.

Authors:  Beth C Holbrook; Jong R Kim; Lance K Blevins; Matthew J Jorgensen; Nancy D Kock; Ralph B D'Agostino; S Tyler Aycock; Mallinath B Hadimani; S Bruce King; Griffith D Parks; Martha A Alexander-Miller
Journal:  J Immunol       Date:  2016-06-08       Impact factor: 5.422

5.  Immune function in healthy adolescents.

Authors:  J A Bartlett; S J Schleifer; M K Demetrikopoulos; B R Delaney; S C Shiflett; S E Keller
Journal:  Clin Diagn Lab Immunol       Date:  1998-01

6.  Reduced primary antigen-specific T-cell precursor frequencies in neonates is associated with deficient interleukin-2 production.

Authors:  J Hassan; D J Reen
Journal:  Immunology       Date:  1996-04       Impact factor: 7.397

7.  Hemagglutination inhibiting antibody persistence 1 year after influenza vaccination in Korean children and adolescents.

Authors:  Eun Kyeong Kang; Byung Wook Eun; Nam Hee Kim; Yun Kyung Kim; Jung Sub Lim; Dong Ho Kim
Journal:  Hum Vaccin Immunother       Date:  2016-12-01       Impact factor: 3.452

8.  Working group consultation: alloimmunity as a vaccine approach against HIV/AIDS: National Institutes of Health Meeting Report, May 24, 2012.

Authors:  Anjali Singh; Jon Warren; Alan Schultz; Charles J Hackett; Opendra Sharma
Journal:  AIDS Res Hum Retroviruses       Date:  2013-04-23       Impact factor: 2.205

9.  Type 1 and type 2 cytokine profiles in children exposed to or infected with vertically transmitted human immunodeficiency virus.

Authors:  B N Lee; J G Lu; M W Kline; M Paul; M Doyle; C Kozinetz; W T Shearer; J M Reuben
Journal:  Clin Diagn Lab Immunol       Date:  1996-09

10.  An R848 adjuvanted influenza vaccine promotes early activation of B cells in the draining lymph nodes of non-human primate neonates.

Authors:  Beth C Holbrook; S Tyler Aycock; Emily Machiele; Elene Clemens; Danielle Gries; Matthew J Jorgensen; Mallinath B Hadimani; S Bruce King; Martha A Alexander-Miller
Journal:  Immunology       Date:  2017-10-24       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.